Oxidative stress influences oocytes (eggs), spermatozoa (sperm), embryos and their environments
This conversion is a major metabolic checkpoint
On the flip side, healthcare professionals need to monitor for potential side effects such as gastrointestinal disturbances, which are common with GLP-1 receptor agonists, and the risk of pancreatitis
The reason retatrutide and the approved GLP-1s are titrated up over months is side effects: in the Phase 2 trial, jumping to high doses without titration nearly doubled gastrointestinal side effects for the same weight loss (The Lancet, 2023)
It suppresses glucagon release, reduces appetite and food cravings, and promotes weight loss and improves glycemic control
Test characteristics Species Human Sample types Serum and EDTA plasma Sample volume 25 L Assay range 0.9 - 940 pmol/L (2.8 - 2940 pg/mL) Detection limit 0.65 pmol/L Incubation 2h + 15 min Detection method Chemiluminescence specificity The following cross-reactions have been tested: GLP-1 (1-36) amide 88% GLP-1 (7-36) amide 93% GLP-1 (9-36) amide 100% GLP-1 (1-37) Not detected GLP-1 (7-37) Not detected Glucagon Not detected GIP Not detected GLP-2 Not detected Oxyntomodulin Not detected Glicentin Not detected Miniglucagon Not detected MPGF Not detected Liraglutide Not detected Exenatide Not detected Lixisenatide Not detected Dulaglutide 0.07% directions for use Certificate of Analysis directions for use Certificate of Analysis SAFETY DATA SHEET technical notes For technical notes specific to Mercodia Total GLP-1 ELISA see: TN34-0154 Sample collection and handling for Mercodia Total GLP-1 ELISA (10-1278-01) references Stinson, S
